Literature DB >> 11403844

Some observations in freeze-drying of recombinant bioluminescent Escherichia coli for toxicity monitoring.

M B Gu1, S H Choi, S W Kim.   

Abstract

A recombinant bioluminescent bacteria, containing a fabA::luxCDABE fusion gene, has been used to characterize freeze-drying methods, which may be conveniently used as a tool for the development of a portable biosensor. Through residual water, viability, biosensing activity and scanning electron microscopy analyses, the characteristics that four cryoprotectants, trehalose, sucrose, sorbitol, and mannitol, conferred on freeze-dried samples were elucidated, including the morphology, water content and activity of the cells. It was found that trehalose showed the best freeze-drying efficiency among the tested cryoprotectants and it might have a specific capacity limitation in protection of the cells during the freeze step. Humidity might result in damage to the cells, according to the viability, when exposed to air during storage, while the water remaining post freeze-drying showed good correlation with damage to the freeze-dried cells when under air-tight storage conditions. The results with other recombinant bioluminescent bacteria indicated that these findings might be general features of the freeze-drying processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403844     DOI: 10.1016/s0168-1656(01)00268-1

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  2 in total

1.  Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.

Authors:  Luciana Meirelles Richer; Miguel Aroso; Tania Contente-Cuomo; Larisa Ivanova; Maria Gomes-Solecki
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

2.  Construction of luminescent Escherichia coli via expressing lux operons and their application on toxicity test.

Authors:  Jun Yang; Shulin Hu; Minhui Wu; Anqi Liao; Shuli Liang; Ying Lin
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-27       Impact factor: 5.560

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.